smegmatis. The data present Potential target genes for MtrA in M.smegmatis. (XLS 40 KB) Vistusertib cost Additional file 6: Homologous target genes recognized by MtrA in M. tuberculosis and M. smegmatis. The data present homologous target genes recognized by MtrA in M. tuberculosis and M. smegmatis. (XLS 18 KB) Additional file 7: Primers used in this study. The data provided primers used in this study. (DOC 28 KB) Additional file 8: Sequences of the DNA substrates used in VX-809 ic50 this study. The data provided sequences of the DNA substrates used in this study. (DOC 31 KB) Additional file 9: Primers used for quantitative real time PCR in this study. The data present the primers used for
quantitative real time PCR in this study. (DOC 70 KB) Additional file 10: Classification and percentage of the target genes containing the 7-bp motif recognized by MtrA in M. smegmatis. The data present the categories and percentage of the target genes containing the 7-bp motif recognized by MtrA in M. smegmatis. (DOC 188 KB) Additional file 11: The data present the categories and percentage of the target genes containing the 7-bp motif recognized by MtrA
in M. tuberculosis. The data present the categories and percentage Selonsertib chemical structure of the target genes containing the 7-bp motif recognized by MtrA in M. tuberculosis. (DOC 212 KB) References 1. Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC: Drug resistance in Mycobacterium tuberculosis . Curr Issues Mol Biol 2006,8(2):97–111.PubMed 2. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M, Global Project on Anti-Tuberculosis Drug Resistance Surveillance: Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance
Surveillance. Lancet 2009,373(9678):1861–1873.PubMedCrossRef 3. Beier D, Gross R: Regulation of bacterial virulence by two-component systems. Curr Opin Microbiol 2006,9(2):143–152.PubMedCrossRef 4. Stock AM, Robinson VL, Goudreau PN: OSBPL9 Two-component signal transduction. Annu Rev Biochem 2000, 69:183–215.PubMedCrossRef 5. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, et al.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998,393(6685):537–544.PubMedCrossRef 6. Zahrt TC, Deretic V: Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc Natl Acad Sci USA 2001,98(22):12706–12711.PubMedCrossRef 7.